K. Yong

发表

Molecular Pathways: Targeted α-Particle Radiation Therapy

M. Brechbiel, K. Baidoo, K. Yong, 2012, Clinical Cancer Research.

Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from 177Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts

M. Brechbiel, D. Milenic, K. Baidoo, 2016, International journal of molecular sciences.

Molecular Pathways Molecular Pathways : Targeted a-Particle Radiation Therapy

M. Brechbiel, K. Baidoo, K. Yong, 2013 .

Application of 212Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.

M. Brechbiel, K. Yong, 2015, AIMS medical science.

Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel

M. Brechbiel, D. Milenic, K. Baidoo, 2014, PloS one.

Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.

M. Brechbiel, D. Milenic, K. Baidoo, 2013, International journal of radiation oncology, biology, physics.

Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

M. Brechbiel, K. Yong, 2011, Dalton transactions.

Gene expression profiling upon 212Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model

M. Brechbiel, D. Milenic, K. Baidoo, 2013, Cancer medicine.

Abstract 1601: Paclitaxel potentiates212Pb-radioimmunotherapy-induced cell killing efficacy by perturbing mitotic spindle checkpoint.

M. Brechbiel, D. Milenic, K. Baidoo, 2013 .

Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model

M. Brechbiel, D. Milenic, K. Baidoo, 2016, PloS one.

212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint

M. Brechbiel, D. Milenic, K. Baidoo, 2013, British Journal of Cancer.

212Pb-Radioimmunotherapy Induces G2 Cell-Cycle Arrest and Delays DNA Damage Repair in Tumor Xenografts in a Model for Disseminated Intraperitoneal Disease

M. Brechbiel, D. Milenic, K. Baidoo, 2012, Molecular Cancer Therapeutics.

Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.

M. Brechbiel, D. Milenic, K. Baidoo, 2013, International journal of radiation oncology, biology, physics.